Follow

"Conclusions: Individuals who have had SARS-CoV-2 infection are unlikely to benefit from COVID-19 vaccination, and vaccines can be safely prioritized to those who have not been infected before." medrxiv.org/content/10.1101/20

Sign in to participate in the conversation
social.wildeboer.net

Mastodon instance for people with Wildeboer as their last name